Literature DB >> 6025496

Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.

J N Shanberge, H Fukui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6025496

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  5 in total

1.  Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital.

Authors:  Junaid H Khan; Emily A Green; Jimmin Chang; Alexandria M Ayala; Marilyn S Barkin; Emily E Reinys; Jeffrey Stanton; Russell D Stanten
Journal:  J Extra Corpor Technol       Date:  2017-12

2.  The heterogeneity of the anticoagulant response to heparin.

Authors:  J W Estes
Journal:  J Clin Pathol       Date:  1972-01       Impact factor: 3.411

3.  [Activity of reagents for thromboplastin-time determination (Quick test) of various manufacturers in changing concentrations of several blood coagulation factors].

Authors:  R Averdunk; J S Braun
Journal:  Blut       Date:  1972-05

4.  Control of heparin therapy.

Authors:  W R Pitney; J E Pettit; L Armstrong
Journal:  Br Med J       Date:  1970-10-17

5.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.